Literature DB >> 1790170

o-acetamidophenylboronate esters stabilized toward hydrolysis by an intramolecular O-B interaction: potential linkers for selective bioconjugation via vicinal diol moieties of carbohydrates.

S X Cai1, J F Keana.   

Abstract

The synthesis and properties of o-acetamidophenylboronic acid 8 and the corresponding 1,2-diol cyclic boronates 13 and 16 are reported. The presence of an O-B interaction in 8 and 13 has been established by 11B and 1H NMR spectroscopy. The O-B interaction stabilizes boronate 13 toward hydrolysis and accelerates esterification of acid 8 in contrast to the non-ortho-substituted boronate 10 and acid 3. The enhanced stability of o-acetamidophenylboronate esters toward hydrolysis suggests their application as vicinal diol protecting groups in carbohydrate synthesis. Through the incorporation of an amino group as a second site for a coupling reaction (e.g. via isothiocyanate 22), o-acetamidophenylboronic acids may serve as novel agents for bioconjugation reactions involving carbohydrate moieties.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1790170     DOI: 10.1021/bc00011a004

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  3 in total

1.  Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry.

Authors:  Alamelu Mahalingam; Anthony R Geonnotti; Jan Balzarini; Patrick F Kiser
Journal:  Mol Pharm       Date:  2011-09-26       Impact factor: 4.939

2.  End-to-end conformational communication through a synthetic purinergic receptor by ligand-induced helicity switching.

Authors:  Robert A Brown; Vincent Diemer; Simon J Webb; Jonathan Clayden
Journal:  Nat Chem       Date:  2013-09-15       Impact factor: 24.427

3.  Glucose-responsive gel from phenylborate polymer and poly(vinyl alcohol): prompt response at physiological pH through the interaction of borate with amino group in the gel.

Authors:  I Hisamitsu; K Kataoka; T Okano; Y Sakurai
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.